S 2103
116th Congress
Senate
Health
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug therapy
Licensing and registrations
Prescription drugs
Affordable Insulin Approvals Now Act
Introduced: July 11, 2019
Introduced by:
Durbin, Richard J.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 11, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Jul 11, 2019
Introduced in Senate
Plain-English summary
Affordable Insulin Approvals Now Act
This bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Committees of jurisdiction
1